RecallRadar

FDA Drug recall D-0628-2024

PEG-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate, and Ascorbic Acid for Oral Solution 100g/7.5 g /2.691 g/1.…

On 2024-08-14 the FDA classified a Class III recall of PEG-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate, and Ascorbic Acid for Oral Solution 100g/7.5 g /2.691 g/1.… by Novel Laboratories D B A Lupin Somerset, citing defective container: potential for non-sealed pouches which can lead to product leakage.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0628-2024
ClassificationClass III
Statusterminated
Initiated2024-07-02
Published2024-08-14
Last updated2026-09-13 11:52 UTC
CompanyNovel Laboratories D B A Lupin Somerset
DistributionUS

Product

PEG-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate, and Ascorbic Acid for Oral Solution 100g/7.5 g /2.691 g/1.015 g/ 5.9 g / 4.7 g, 3 pouches/carton, Rx only, Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC# 0093-3560-26.

Reason

Defective container: potential for non-sealed pouches which can lead to product leakage.

Identifiers

ndc0093-3560-19
ndc0093-3560-26
ndc0093-9044-19
ndc0093-9043-19
code_infoLot #S300542, exp. date June 30, 2025

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0628-2024%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.